Procter & Gamble Hygiene and Healthcare Ltd. (PGHH) has reported a subdued performance for the year ended June 2001. While the company's revenues declined by 6%, profits were up by a marginal 10%.
Operating Profit (EBDIT)
Operating Profit Margin (%)
Profit before Tax
Profit after Tax/(Loss)
Net profit margin (%)
No. of Shares (eoy) (m)
Diluted Earnings per share
P/E (at current price)
The sales figures in June '01 are however, not comparable as the previous year's figures included revenues from divested businesses such as manufacture of shampoos and Clearasil amounting to Rs 420 m. Excluding this, topline has actually grown by 3%. Strong competition from lower end brands has taken a toll on the company's volume growth.
PGHH has successfully improved its operating margins (OPM) by 1% in FY01. The company's margins are the highest amongst its peers in the sector. Its focus on value growth has enabled it to maintain its OPM on the higher level. Also, removal of excise duty on feminine care products in the Union Budget 2000-01, has contributed in boosting the margins.
Efficient working capital management has led to a decline in interest cost of the company by a significant 93% in FY01. PGHH's other income in FY01 grew by over 166%. The figure included proceeds from sale of some immovable properties at Mumbai. This company has repaid its debts with this additional inflow. Also, with no plans for further capacity addition, it has declared an extraordinary dividend of Rs 40 per share for the year. This would enhance its returns on capital employed from 39% in FY00 to about 48% in FY01.
At the current market price of Rs 530 PGHH is trading at a P/E of 14x and market cap to sales ratio of 2.6x on FY01 earnings. The stock is accorded lower valuations by the markets because of the company's dependence on two brands. P&G's (parent company) wholly owned subsidiary, P&G Home Products Ltd. has also raised concerns among the investors.
Procter & Gamble Hygiene and Health Care has announced the first quarter results of the financial year ended June 2017 (1QFY17). The company's sales rose by 12.5%YoY while net profit rose by 50.1% YoY during the quarter.
LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA or Canada, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.
Equitymaster Agora Research Private Limited. 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India. Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: email@example.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407